| 1 |
34250544 | Identification of the JNK-Active Triple-Negative Breast Cancer Cluster Associated With an Immunosuppressive Tumor Microenvironment. | 2022 Jan 11 |
1 |
| 2 |
34600802 | Poor clinical outcomes and immunoevasive contexture in SIRPα+ tumor-associated macrophages enriched muscle-invasive bladder cancer patients. | 2022 Mar |
1 |
| 3 |
35615815 | Crosstalk between IL-15Rα+ tumor-associated macrophages and breast cancer cells reduces CD8+ T cell recruitment. | 2022 Jun |
1 |
| 4 |
35623342 | Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer. | 2022 Jun 13 |
1 |
| 5 |
33637602 | CXCL9-expressing tumor-associated macrophages: new players in the fight against cancer. | 2021 Feb |
1 |
| 6 |
33749663 | Hedgehog-induced PD-L1 on tumor-associated macrophages is critical for suppression of tumor-infiltrating CD8+ T cell function. | 2021 Mar 22 |
1 |
| 7 |
34019807 | The loss of RNA N6-adenosine methyltransferase Mettl14 in tumor-associated macrophages promotes CD8+ T cell dysfunction and tumor growth. | 2021 Jul 12 |
1 |
| 8 |
34079767 | PD-1-Positive Tumor-Associated Macrophages Define Poor Clinical Outcomes in Patients With Muscle Invasive Bladder Cancer Through Potential CD68/PD-1 Complex Interactions. | 2021 |
1 |
| 9 |
34112250 | Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma. | 2021 Jun 10 |
1 |
| 10 |
34485116 | Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients. | 2021 |
1 |
| 11 |
29467128 | Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors. | 2018 Apr |
1 |
| 12 |
29875321 | Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy. | 2018 Jun 7 |
2 |